Skip to main navigation Skip to search Skip to main content

Autolus EAP: Expanded Access Program (EAP) for Obecabtagene Autoleucel (obe-cel) Out-of-specification (OOS) in Adult Patients with Acute Lymphoblastic Leukemia

Grants and Contracts Details

StatusActive
Effective start/end date9/11/25 → 9/11/27

Funding

  • Autolus Inc: $2.00